BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30442374)

  • 1. Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatment.
    Llàcer P; Bayés-Genís A; Núñez J
    Med Clin (Barc); 2019 Apr; 152(7):266-273. PubMed ID: 30442374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of antigen carbohydrate 125 in heart failure.
    Núñez J; Miñana G; Núñez E; Chorro FJ; Bodí V; Sanchis J
    Heart Fail Rev; 2014 Sep; 19(5):575-84. PubMed ID: 23925386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
    Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
    Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA125: An Increasingly Promising Biomarker of Heart Failure.
    Pan C; Zhou M; Jian Y; Zeng Y; Wang M; Chen F
    Curr Pharm Des; 2021; 27(37):3871-3880. PubMed ID: 33461452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
    García-Blas S; Bonanad C; Llàcer P; Ventura S; Núñez JM; Sánchez R; Chamorro C; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Ortiz V; Racugno P; Bodí V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Bondanza L; Payá A; Cardells I; Heredia R; Pellicer M; Valls G; Palau P; Bosch MJ; Raso R; Sánchez A; Bertomeu-González V; Bertomeu-Martínez V; Montagud-Balaguer V; Albiach-Montañana C; Pendás-Meneau J; Marcaida G; Cervantes-García S; San Antonio R; de Mingo E; Chorro FJ; Sanchis J; Núñez J;
    Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1067-1073. PubMed ID: 28341415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
    Núñez J; de la Espriella R; Miñana G; Santas E; Llácer P; Núñez E; Palau P; Bodí V; Chorro FJ; Sanchis J; Lupón J; Bayés-Genís A
    Eur J Heart Fail; 2021 Sep; 23(9):1445-1457. PubMed ID: 34241936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
    Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
    Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate antigen 125: a new biomarker in heart failure.
    Vizzardi E; D'Aloia A; Curnis A; Dei Cas L
    Cardiol Rev; 2013; 21(1):23-6. PubMed ID: 22735832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
    Núñez J; Bayés-Genís A; Revuelta-López E; Miñana G; Santas E; Ter Maaten JM; de la Espriella R; Carratalá A; Lorenzo M; Palau P; Llàcer P; Valle A; Bodi V; Núñez E; Lupón J; Lang C; Ng LL; Metra M; Sanchis J; Voors AA
    Rev Esp Cardiol (Engl Ed); 2022 Apr; 75(4):316-324. PubMed ID: 33745912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
    Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
    Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
    Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
    JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the clinical implications of carbohydrate antigen 125 as a biomarker of heart failure: a meta-analysis and systematic review of published studies.
    Zhuang J; Faggiano P; Li Q; Pradelli D; Med V; Peng W; Zuo M; Xu Y
    J Cardiovasc Med (Hagerstown); 2014 Dec; 15(12):864-72. PubMed ID: 25353973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].
    Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of thoracic sonography for follow-up examination of chronic heart failure patients with previous decompensation.
    Kataoka H
    Clin Cardiol; 2007 Jul; 30(7):336-41. PubMed ID: 17674378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
    D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
    J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
    Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
    Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
    Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
    Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure.
    Kumric M; Kurir TT; Bozic J; Glavas D; Saric T; Marcelius B; D'Amario D; Borovac JA
    Card Fail Rev; 2021 Mar; 7():e19. PubMed ID: 34950509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
    Stanciu AE; Stanciu MM; Vatasescu RG
    Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of carbohydrate antigen-125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women.
    Hung CL; Hung TC; Liu CC; Wu YJ; Kuo JY; Hou CJ; Yeh HI
    Am J Cardiol; 2012 Oct; 110(7):993-1000. PubMed ID: 22728006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.